Rakuten Medical has added to its tally of megarounds, pocketing another $100 million to push its lead light-based cancer therapy toward…

Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its…

In the quest to unravel the complexities of ecosystem stability, a recent groundbreaking study has illuminated the profound impact of…

The intricate world of malaria parasites, particularly Plasmodium falciparum, continues to reveal its mysteries through ongoing scientific advancements. Recently, a…

In a groundbreaking development poised to reshape synthetic organic chemistry, researchers have unveiled a novel catalytic cascade that achieves an…

In an innovative stride toward combating antibiotic resistance, a groundbreaking study has emerged from a collaborative effort led by researchers…

In an innovative study published in the journal “Discover Animals,” researchers have explored the potential of sweet potato leaf silage…

Basilea Pharmaceutica is continuing its quest to develop much-needed new antifungal drugs by penning a deal with Prokaryotics.  The collaboration…

GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3…

A phase 3 trial of Hutchmed’s autoimmune disease candidate sovleplenib has hit its primary endpoint, delivering a boost to an asset…